TNFRSF19 and lung cancer: The survival analysis of 1145 lung cancer patients for more than 200 months showed the survival time was significantly longer for patients with high expression of TNFRSF19 than with low expression [35] (p = 1.8e−09, log-rank test; Fig. 7g).